Get the Stockscreener App
5.99
2.57%
0.15
After Hours:
5.99
Fennec Pharmaceuticals Inc Stock (FENC) Forecast
The Fennec Pharmaceuticals Inc (FENC) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $11.90, representing a +98.63% increase from the current price of $5.99. The highest analyst price target is $12.39, and the lowest is $11.40.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month FENC Price Target
Average 13.81
(+130.57% Upside)
Is Fennec Pharmaceuticals Inc (FENC) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 57.60 | Neutral |
| STOCH(9,6) | 47.59 | Neutral |
| STOCHRSI(14) | 28.96 | Neutral |
| MACD(12,26) | 0.2502 | Sell |
| ADX(14) | 23.54 | Neutral |
| William %R | -47.83 | Neutral |
| CCI(14) | -18.88 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.001
Sell
|
5.9317
Buy
|
| MA20 |
5.9765
Buy
|
5.7729
Buy
|
| MA50 |
5.0846
Buy
|
5.4174
Buy
|
| MA100 |
5.2116
Buy
|
5.564
Buy
|
| MA200 |
6.7079
Sell
|
6.2563
Sell
|
Buy: 7
Sell: 3
Neutral: 0
Summary: Buy
According to our latest analysis, FENC could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 4 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on FENC, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 57.6 indicates that FENC is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 47.59 indicates that FENC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 28.96 indicates that FENC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.54 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -18.88 indicates that FENC is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term FENC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Fennec Pharmaceuticals Inc financial reports and earnings history, Fennec Pharmaceuticals Inc (FENC) stock could reach $14.35 by 2030, $37.72 by 2040 and $46.85 by 2050. See the projected annual prices until 2050 of the Fennec Pharmaceuticals Inc stock below:
- Fennec Pharmaceuticals Inc (FENC) is expected to reach an average price of $29.32 in 2035, with a high prediction of $29.42 and a low estimate of $26.87. This indicates an $389.42% rise from the last recorded price of $5.99.
- Fennec Pharmaceuticals Inc (FENC) stock is projected to chart a bullish course in 2040, with an average price target of $36.87, representing an $515.54% surge from its current level. The forecast ranges from a conservative $36.26 to a sky-high $37.72.
- Our analysts predict Fennec Pharmaceuticals Inc (FENC) to jump 624.37% by 2045, soaring from $41.80 to an average price of $43.39, potentially reaching $44.20. While $41.80 is the low estimate, the potential upside is significant.
- Fennec Pharmaceuticals Inc (FENC) stock is expected to climb by 2050, reaching an average of $46.80, a $681.34% jump from its current level. However, a wide range of estimates exists, with high and low targets of $46.85 and $45.94, respectively, highlighting the market's uncertainty.
Fennec Pharmaceuticals Inc Stock (FENC) Year by Year Forecast
Fennec Pharmaceuticals Inc Stock (FENC) Price Forecast for 2025
Fennec Pharmaceuticals Inc Stock (FENC) is expected to reach an average price of $13.81 in 2025, with a high prediction of $17.06 and a low estimate of $10.56. This indicates an +130.57% rise from the last recorded price of $5.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $12.25 | $11.40 | $12.39 | +104.55% |
| February, 2025 | $12.40 | $11.53 | $14.13 | +107.05% |
| March, 2025 | $12.68 | $12.18 | $14.03 | +111.72% |
| April, 2025 | $11.91 | $10.56 | $13.80 | +98.86% |
| May, 2025 | $13.23 | $11.15 | $13.95 | +120.89% |
| June, 2025 | $13.45 | $12.01 | $14.07 | +124.56% |
| July, 2025 | $15.33 | $13.33 | $15.89 | +155.94% |
| August, 2025 | $14.56 | $14.15 | $15.98 | +143.08% |
| September, 2025 | $15.35 | $14.25 | $15.97 | +156.30% |
| October, 2025 | $11.66 | $11.27 | $17.06 | +94.66% |
| November, 2025 | $12.61 | $11.49 | $13.10 | +110.52% |
| December, 2025 | $14.21 | $12.50 | $14.77 | +137.22% |
Fennec Pharmaceuticals Inc Stock (FENC) Price Forecast for 2026
The predicted value for Fennec Pharmaceuticals Inc (FENC) in 2026 is set at an average of $15.26. Estimates vary from a peak of $17.52 to a trough of $13.01, indicating an +154.79% surge from the present price of $5.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $14.47 | $13.53 | $15.46 | +141.56% |
| February, 2026 | $14.24 | $13.44 | $15.15 | +137.71% |
| March, 2026 | $14.32 | $13.35 | $14.83 | +139.05% |
| April, 2026 | $15.07 | $13.98 | $15.81 | +151.56% |
| May, 2026 | $14.19 | $13.76 | $15.37 | +136.87% |
| June, 2026 | $13.43 | $13.01 | $14.40 | +124.17% |
| July, 2026 | $13.56 | $13.05 | $14.34 | +126.34% |
| August, 2026 | $14.10 | $13.50 | $15.09 | +135.35% |
| September, 2026 | $14.06 | $13.67 | $15.33 | +134.68% |
| October, 2026 | $14.31 | $13.84 | $14.51 | +138.85% |
| November, 2026 | $15.51 | $14.23 | $15.78 | +158.87% |
| December, 2026 | $17.14 | $15.37 | $17.52 | +186.08% |
Fennec Pharmaceuticals Inc Stock (FENC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Fennec Pharmaceuticals Inc (FENC) is $14.82, with a high forecast of $17.92 and a low forecast of $11.73. This indicates an +147.44% increase from the last price of $5.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $16.52 | $16.27 | $17.35 | +175.73% |
| February, 2027 | $17.67 | $16.47 | $17.90 | +195.00% |
| March, 2027 | $12.03 | $11.73 | $17.92 | +100.76% |
| April, 2027 | $12.66 | $12.00 | $12.85 | +111.27% |
| May, 2027 | $12.87 | $12.18 | $13.05 | +114.86% |
| June, 2027 | $13.28 | $12.80 | $13.98 | +121.78% |
| July, 2027 | $13.88 | $13.04 | $14.63 | +131.79% |
| August, 2027 | $14.33 | $13.84 | $14.87 | +139.30% |
| September, 2027 | $14.28 | $13.42 | $14.75 | +138.46% |
| October, 2027 | $14.04 | $13.81 | $14.44 | +134.45% |
| November, 2027 | $15.00 | $14.07 | $15.12 | +150.47% |
| December, 2027 | $15.66 | $14.82 | $16.29 | +161.49% |
Fennec Pharmaceuticals Inc Stock (FENC) Price Forecast for 2028
In 2028, Fennec Pharmaceuticals Inc (FENC) is projected to reach an average price of $17.52, with a high projection of $20.07 and a low estimate of $14.97. This indicates an +192.53% rise from the last price of $5.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $16.19 | $14.97 | $16.40 | +170.33% |
| February, 2028 | $16.98 | $15.11 | $17.61 | +183.51% |
| March, 2028 | $17.78 | $16.27 | $17.83 | +196.86% |
| April, 2028 | $18.57 | $16.71 | $18.93 | +210.05% |
| May, 2028 | $18.94 | $17.95 | $19.52 | +216.22% |
| June, 2028 | $19.14 | $18.55 | $20.07 | +219.56% |
| July, 2028 | $19.12 | $18.36 | $19.80 | +219.22% |
| August, 2028 | $18.26 | $17.87 | $19.23 | +204.85% |
| September, 2028 | $17.99 | $16.48 | $18.59 | +200.34% |
| October, 2028 | $17.77 | $17.14 | $18.68 | +196.67% |
| November, 2028 | $17.90 | $16.74 | $17.97 | +198.83% |
| December, 2028 | $18.59 | $17.81 | $19.74 | +210.35% |
Fennec Pharmaceuticals Inc Stock (FENC) Price Forecast for 2029
The 2029 price forecast for Fennec Pharmaceuticals Inc Stock (FENC) is $18.12 on average, with a high prediction of $22.28 and a low estimate of $13.97. This represents an +202.57% increase from the previous price of $5.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $18.77 | $17.60 | $18.88 | +213.35% |
| February, 2029 | $18.14 | $17.58 | $18.66 | +202.82% |
| March, 2029 | $17.95 | $17.66 | $18.46 | +199.65% |
| April, 2029 | $17.00 | $16.38 | $17.99 | +183.78% |
| May, 2029 | $17.78 | $16.71 | $18.44 | +196.80% |
| June, 2029 | $18.93 | $17.82 | $19.18 | +215.99% |
| July, 2029 | $21.58 | $18.87 | $22.28 | +260.23% |
| August, 2029 | $20.45 | $20.01 | $21.65 | +241.36% |
| September, 2029 | $19.54 | $19.13 | $20.93 | +226.16% |
| October, 2029 | $21.44 | $19.54 | $22.13 | +257.88% |
| November, 2029 | $20.06 | $19.89 | $22.03 | +234.84% |
| December, 2029 | $14.02 | $13.97 | $20.35 | +134.14% |
Fennec Pharmaceuticals Inc Stock (FENC) Price Forecast for 2030
Fennec Pharmaceuticals Inc Stock (FENC) is expected to reach an average price of $16.59 in 2030, with a high forecast of $19.86 and a low forecast of $13.32. This signifies an +177.04% surge from the last price of $5.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $13.90 | $13.32 | $14.35 | +132.04% |
| February, 2030 | $14.43 | $13.77 | $14.64 | +140.88% |
| March, 2030 | $15.00 | $14.08 | $15.32 | +150.39% |
| April, 2030 | $14.85 | $14.42 | $15.36 | +147.88% |
| May, 2030 | $15.55 | $14.83 | $15.74 | +159.55% |
| June, 2030 | $15.77 | $14.99 | $15.89 | +163.33% |
| July, 2030 | $16.86 | $15.75 | $17.07 | +181.40% |
| August, 2030 | $17.27 | $16.72 | $17.87 | +188.24% |
| September, 2030 | $18.33 | $17.11 | $18.43 | +205.93% |
| October, 2030 | $19.47 | $17.30 | $19.86 | +224.99% |
| November, 2030 | $17.41 | $17.11 | $19.86 | +190.72% |
| December, 2030 | $17.40 | $16.47 | $17.86 | +190.47% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):